PortfoliosLab logo

ALX Oncology Holdings Inc. (ALXO)

Equity · Currency in USD · Last updated Jan 28, 2023

Company Info

ISINUS00166B1052
CUSIP00166B105
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$9.18
Year Range$5.89 - $20.00
EMA (50)$10.40
EMA (200)$12.03
Average Volume$174.60K
Market Capitalization$383.10M

ALXOShare Price Chart


Loading data...

ALXOPerformance

The chart shows the growth of $10,000 invested in ALX Oncology Holdings Inc. in Aug 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,060 for a total return of roughly -69.40%. All prices are adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2023
-6.62%
-0.50%
ALXO (ALX Oncology Holdings Inc.)
Benchmark (^GSPC)

ALXOCompare to other instruments

Search for stocks, ETFs, and funds to compare with ALXO

ALX Oncology Holdings Inc.

ALXOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD-18.54%6.02%
1M-14.53%6.30%
6M-16.85%-0.05%
1Y-37.42%-6.42%
5Y-37.40%9.65%
10Y-37.40%9.65%

ALXOMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202219.65%34.30%-26.38%26.85%-8.57%1.53%

ALXOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ALX Oncology Holdings Inc. Sharpe ratio is -0.47. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20SeptemberOctoberNovemberDecember2023
-0.47
-0.27
ALXO (ALX Oncology Holdings Inc.)
Benchmark (^GSPC)

ALXODividend History


ALX Oncology Holdings Inc. doesn't pay dividends

ALXODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%SeptemberOctoberNovemberDecember2023
-91.82%
-15.14%
ALXO (ALX Oncology Holdings Inc.)
Benchmark (^GSPC)

ALXOWorst Drawdowns

The table below shows the maximum drawdowns of the ALX Oncology Holdings Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ALX Oncology Holdings Inc. is 94.75%, recorded on Jun 16, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-94.75%Dec 11, 2020381Jun 16, 2022
-27.58%Aug 18, 202032Oct 1, 202028Nov 10, 202060
-17.51%Nov 24, 20202Nov 25, 202010Dec 10, 202012
-7.17%Aug 10, 20202Aug 11, 20203Aug 14, 20205
-4.58%Jul 22, 20201Jul 22, 20204Jul 28, 20205
-2.91%Jul 29, 20201Jul 29, 20202Jul 31, 20203
-1.99%Nov 13, 20201Nov 13, 20201Nov 16, 20202
-1.65%Nov 18, 20201Nov 18, 20201Nov 19, 20202

ALXOVolatility Chart

Current ALX Oncology Holdings Inc. volatility is 36.60%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%SeptemberOctoberNovemberDecember2023
36.60%
16.76%
ALXO (ALX Oncology Holdings Inc.)
Benchmark (^GSPC)